NCT05871424View on ClinicalTrials.gov

Transdermal Buprenorphine Patch for Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 11, 2023

Primary Completion Date

February 14, 2024

Study Completion Date

February 14, 2024

Conditions
Laparoscopic Cholecystectomy
Interventions
DRUG

buprenorphine patch group

5 mcg/h buprenorphine patch will be applied preoperatively

DRUG

placebo group

simple dressing tape only will be applied

Trial Locations (1)

Unknown

Gangnam Severance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT05871424 - Transdermal Buprenorphine Patch for Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter